4-Methylmorpholine → rac-N-(2-Amino-2,4-dimethylpentyl)-2,6-dimethyl-8-(3-methylbutoxy)imidazo[1,2-a]pyridine-3-carboxamide
反応式
[CH3:1][C:2]1[N:3]=[C:4]2[C:9]([O:10][CH2:11][CH2:12][CH:13]([CH3:15])[CH3:14])=[CH:8][C:7]([CH3:16])=[CH:6][N:5]2[C:17]=1[C:18]([OH:20])=O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CN1CCOCC1.[CH3:50][C:51]([NH2:58])([CH2:54][CH:55]([CH3:57])[CH3:56])[CH2:52][NH2:53]>CN(C=O)C.O.C(O)(C(F)(F)F)=O>[NH2:58][C:51]([CH3:50])([CH2:54][CH:55]([CH3:57])[CH3:56])[CH2:52][NH:53][C:18]([C:17]1[N:5]2[CH:6]=[C:7]([CH3:16])[CH:8]=[C:9]([O:10][CH2:11][CH2:12][CH:13]([CH3:14])[CH3:15])[C:4]2=[N:3][C:2]=1[CH3:1])=[O:20]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
175 mg (0.63 mmol) of 2,6-dimethyl-8-(3-methylbutoxy)imidazo[1,2-a]pyridine-3-carboxylic acid Example 252A were initially charged in DMF (2.2 ml), 214 mg (0.67 mmol) of TBTU, 0.28 ml (2.53 mmol) of 4-methylmorpholine and 91 mg (0.70 mmol) of rac-2,4-dimethylpentane-1,2-diamine were added and the reaction mixture stirred at RT overnight. The mixture was diluted with water/TFA and purified by preparative RP-HPLC (acetonitrile/water gradient with addition of 0.1% TFA). After concentration, saturated aqueous sodium bicarbonate solution was added to the residue and the mixture was extracted three times with dichloromethane. The combined organic phases were dried over sodium sulphate, filtered off and concentrated. This gave 225 mg (90% of theory, purity 98%) of the target compound.
後処理
- custompurified by preparative RP-HPLC (acetonitrile/water gradient with addition of 0.1% TFA)
- concentrationAfter concentration, saturated aqueous sodium bicarbonate solution
- additionwas added to the residue
- extractionthe mixture was extracted three times with dichloromethane
- dry with materialThe combined organic phases were dried over sodium sulphate
- filtrationfiltered off
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-3ae1f4ecca0142faacdeb42f0bdc855e
- 出典データセット
- uspto-grants-2015_09
- 特許番号
- US09126998B2
反応ノート
読み込み中…